Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
29.02
-0.34 (-1.16%)
At close: May 6, 2026, 4:00 PM EDT
28.50
-0.52 (-1.79%)
After-hours: May 6, 2026, 7:30 PM EDT
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $546.98 million as of May 6, 2026. Its market cap has increased by 63.55% in one year.
Market Cap
546.98M
Enterprise Value
296.63M
1-Year Change
63.55%
Ranking
Category
Stock Price
$29.02
Market Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $546.98M, an increase of 118.24%. That is a compound annual growth rate of 51.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 553.39M | 41.74% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
| Jun 21, 2024 | 250.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 586.48M |
| Prothena Corporation | 580.86M |
| Entrada Therapeutics | 576.91M |
| Ginkgo Bioworks Holdings | 576.83M |
| ProKidney | 567.69M |
| Eikon Therapeutics | 556.00M |
| Candel Therapeutics | 551.55M |
| Rigel Pharmaceuticals | 545.90M |